Series B · Biotech · Dublin, Ireland · Founded 2019 · 101–250 employees
SOMAÍ Pharmaceuticals is a leading EU-GMP certified pharmaceutical company specializing in cannabis-based therapeutics with manufacturing facilities in Lisbon, Portugal and global distribution. Founded by experienced executive Michael Sassano, the company focuses on developing cannabinoid-containing pharmaceuticals including oral solutions, inhalation oils and transdermal patches. SOMAÍ operates as one of Europe's few vertically integrated Multi-Country Operators with state-of-the-art extraction and cultivation facilities. The company has secured Series B funding and continues expanding globally with partnerships including major cannabis brands.